Text Size

Significant Pathology Associated With Crossed Leg Sign

This study is not yet open for participant recruitment.
Verified March 2012 by Uelk, J. Daniel, D.O.
Sponsor:
Information provided by (Responsible Party):
Uelk, J. Daniel, D.O.
ClinicalTrials.gov Identifier:
NCT01569555
First received: March 30, 2012
Last updated: NA
Last verified: March 2012
History: No changes posted
  Purpose

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.


Condition
Pathology

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Crossed Leg Sign and it's Correlation With Significant Pathology

Further study details as provided by Uelk, J. Daniel, D.O.:

Estimated Enrollment: 400
Study Start Date: May 2012
Estimated Study Completion Date: February 2013
Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Detailed Description:

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology. Therefore, by determining the sensitivity and specificity of this physical exam finding, the clinician would have a better idea of the patients clinical management, including diagnostic testing and ultimate treatment of the patient. Crossed Leg Sign will be defined in this study as: any patient observed in the Emergency Department with sustained crossed legs. To my knowledge, crossed legs have never been evaluated in regards to it's correlation with significant pathology. This could potentially add another physical exam finding to be used by the clinician.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

This study should include all comers. To exclude a patient population would add a selection bias.

Criteria

Inclusion Criteria:

  • Any patient observed in the Emergency Department with sustained crossed legs.

Exclusion Criteria:

  • Any patient not observed to have sustained crossed legs and is not being used as a control.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01569555

Contacts
Contact: John D Uelk, DO 314-605-4486 juelk1@hfhs.org
Contact: Michael Ward, DO 908-930-2405 mward4@hfhs.org

Locations
United States, Michigan
Henry Ford Wyandotte Hospital Not yet recruiting
Wyandotte, Michigan, United States, 48192
Contact: John D Uelk, DO     314-605-4486     juelk1@hfhs.org    
Principal Investigator: John D Uelk, DO            
Sponsors and Collaborators
Uelk, J. Daniel, D.O.
Investigators
Principal Investigator: John D Uelk, DO Henry Ford Health System
  More Information

No publications provided

Responsible Party: Uelk, J. Daniel, D.O.
ClinicalTrials.gov Identifier: NCT01569555     History of Changes
Other Study ID Numbers: 7286
Study First Received: March 30, 2012
Last Updated: March 30, 2012
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on May 22, 2013